Halcion An Independent Assessment of Safety and Efficacy Data (1997) / Chapter Skim
Currently Skimming:
References
References
Pages 97-106
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 97... ...
1987. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity.
|
From page 98... ...
1991. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness.
|
From page 99... ...
1996. Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes.
|
From page 100... ...
Food and Drug Administration, Rockville, Maryland.
|
From page 101... ...
U.S. Food and Drug Administration, Rockville, Maryland.
|
From page 102... ...
1994. The efficacy and memory effects of oral triazolam premedication in highly anxious dental patients.
|
From page 103... ...
1996. Chronic triazolam and its withdrawal alters GABAA receptor subunit mRNA levels: an in situ hybridization study.
|
From page 104... ...
1989. Peripheral, but not local or intracerebroventricular, administration of benzodiazepines attenuates evoked activity of locus coeruleus neurons.
|
From page 105... ...
1992. Advisory Committee Brochure on Halcion Tablets, prepared for the Psychopharmacological Drugs Advisory Committee Meeting No.
|
From page 106... ...
1991. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's spontaneous reporting system.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.